John Bernard Payne is CEO & President at Zivo Bioscience, Inc. (ZIVO). They have made 5 open-market trades across 1 company since 2022, most recently 2026-01-26.
CIK 0001582392
5 open-market purchases totalling $224K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVET | 10,800 | $73K |
| ZIVO | 19,618 | $22K |
| Total | $94K |
Shares reported on the most recent Form 4, priced at the 2026-01-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZIVO | BUY | 2026-01-26 | 2026-01-28 | $8.54 | $100K | N/A | N/A | N/A |
| ZIVO | BUY | 2024-10-16 | 2024-10-16 | $15.76 | $100K | +0.0% | +0.0% | +0.0% |
| ZIVO | BUY | 2024-10-16 | 2024-10-16 | $0.16 | $1000 | +0.0% | +0.0% | +0.0% |
| ZIVO | BUY | 2022-12-19 | 2022-12-20 | $2.50 | $143 | -0.4% | +19.6% | +30.8% |
| ZIVO | BUY | 2022-01-25 | 2022-01-28 | $2.50 | $23K | +37.9% | +36.0% | +29.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.